We used fiscal 2023 data for companies with fiscal years that end in June or September such as Accuray, Asahi Intecc, BD, Cardinal Health, Carl Zeiss, Cochlear, Electromed, Embecta, Hologic, ResMed ...

Since its inception in 2009, Air Voel has been a pioneer in helping Canadians manage their sleep apnea effectively. As a leading online provider of CPAP supplies, Air Voel has established itself as a ...

ResMed unveils its 2030 strategy with revenue expected to grow in high single digits ... Before his discovery, understanding of the physiology of this nerve – which supplies the heart, airways and ...

Fears that GLP-1 obesity drugs would reduce demand for ResMed’s various CPAP airflow machines have proven unfounded..

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Ellen Airhart Ellen Airhart writes about emergency preparedness and ...

Investors seem to be signalling out ResMed for punishment. Whilst the ASX 200 is having a bad day, it's been far worse for Resmed shares. This ASX 200 healthcare stock closed at $36.25 a share ...

As the title of this article gave away, that company is ResMed (NYSE:RMD), a fast-growing healthcare company. My most recent article on this company was published on October 30, 2023. Back then ...